Astellas Pharma Technologies
How we got $838K
Based on typical figures for its industry (2022 Economic Census), not its own records.
What we know
Signs of a sale Unlikely to sell soon
- In business 22 years (since 2004)
From public records and the company's website, not a statement that it's for sale.
What they do
Astellas is a global life sciences company that develops medicines and says it turns innovative science into value for patients. The pages describe therapies in oncology, ophthalmology, urology, immunology and women's health, and it is headquartered in Tokyo, Japan.
From the company's website. Industry: Retail Trade.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| Astellas Pharma Technologies this business | $4.6M | — |
| Norman Super Mart Norman | $5.2M | 0.4 mi |
| Circle K Norman | $3.0M | 0.8 mi |
| Phillips 66 Norman | $5.2M | 0.8 mi |
| Shell Norman | $5.2M | 0.8 mi |
| ONCUE 139 Norman | $5.2M | 0.8 mi |
| Last Call Wine and Spirits Norman | $3.0M | 0.8 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $838K |
| Multiple for this size and industry | 2.4× |
| Value range | $204K – $1.3M |
This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Retail Trade businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (8%). Treat these as a rough guide.
| Revenue range | $1.4M – $6.1M |
| EBITDA range | $106K – $459K |
| Industry (NAICS) | Retail Trade (446) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: approximate sector default. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Astellas Pharma Technologies
Astellas Pharma Technologies is a retail trade company in Norman, Oklahoma, in business since 2004. Its estimated annual revenue is about $4.6M, with roughly $349K of EBITDA. Its estimated business value is $838K (likely range $204K–$1.3M).
Common questions
- Who owns Astellas Pharma Technologies?
- The owner of Astellas Pharma Technologies isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Astellas Pharma Technologies make?
- SeeBITDA estimates Astellas Pharma Technologies's annual revenue at about $4.6M (likely between $1.4M and $6.1M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Astellas Pharma Technologies worth?
- About $838K, roughly 2.4× its estimated EBITDA of $349K, typical for a retail trade company its size. Likely range: $204K–$1.3M.
- When was Astellas Pharma Technologies founded?
- Astellas Pharma Technologies has been in business since 2004.